82 FR 48103 - Advisory Committee on Heritable Disorders in Newborns and Children
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 82, Issue 198 (October 16, 2017)
Health Resources and Services Administration
Federal Register Volume 82, Issue 198 (October 16, 2017)
| Page Range | 48103-48104 | |
| FR Document | 2017-22313 |
[Federal Register Volume 82, Number 198 (Monday, October 16, 2017)] [Notices] [Pages 48103-48104] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-22313] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Committee on Heritable Disorders in Newborns and Children AGENCY: Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: In accordance with the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). This meeting will be open to the public but advance registration is required. Please register online at http://www.achdncmeetings.org/ by 12:00 p.m. Eastern Time on November 6, 2017. Information about the ACHDNC can be obtained by accessing the following Web site: https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/index.html. DATES: The meeting will be held on Wednesday, November 8, 2017, 9:30 a.m. to 5:00 p.m. Eastern Time and Thursday, November 9, 2017, 9:30 a.m. to 3:00 p.m. Eastern Time (meeting times are tentative). ADDRESSES: This meeting will be held in-person at 5600 Fishers Lane, 5th Floor Pavilion, Rockville, MD 20857. The meeting will also be accessible via Webcast. Instructions on how to access the meeting via Webcast will be provided upon registration. Please note, the 5600 Fishers Lane building requires security screening on entry. Visitors must provide a driver's license, passport, or other form of government- issued photo identification to be granted entry into the facility. Non- US Citizens planning to attend in person will need [[Page 48104]] to provide additional information to HRSA by October 24, 2017, 12:00 p.m. Eastern Time. Please see contact information below. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACHDNC should contact Ann Ferrero, Maternal and Child Health Bureau (MCHB), HRSA, in one of three ways: (1) Send a request to the following address: Ann Ferrero, MCHB, HRSA 5600 Fishers Lane, Room 18N100C, Rockville, MD 20857; (2) call 301-443-3999; or (3) send an email to: [email protected]. SUPPLEMENTARY INFORMATION: The ACHDNC provides advice to the Secretary of HHS on the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. In addition, ACHDNC's recommendations regarding inclusion of additional conditions and inherited disorders for screening which have been adopted by the Secretary are then included in the Recommended Uniform Screening Panel (RUSP). Conditions listed on the RUSP constitute part of the comprehensive preventive health guidelines supported by HRSA for infants and children under section 2713 of the Public Health Service Act, codified at 42 U.S.C. 300gg-13. Under this provision, non-grandfathered health plans are required to cover screenings included in the HRSA-supported comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years (i.e., policy years) beginning on or after the date that is one year from the Secretary's adoption of the condition for screening. The meeting agenda will include: (1) An update on states' progress toward the newborn screening timeliness goals outlined by the Committee; (2) a presentation on phase 2 of the spinal muscular atrophy evidence review; (3) presentations on newborn screening topics such as the clinical and public health impact of Severe Combined Immunodeficiency (SCID), carrier status in the context of newborn screening, and a review of long term follow up in newborn screening; and (4) updates from the Laboratory Standards and Procedures workgroup, Follow-up and Treatment workgroup, and Education and Training workgroup. The Committee will not be voting on a proposed addition of a condition to the RUSP. Agenda items are subject to change. The final meeting agenda will be available 2 days prior to the meeting on the Committee's Web site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders. Members of the public will have the opportunity to provide comments. All comments are part of the official Committee record. To submit written comments or request time for an oral comment at the meeting, please register online by 11:59 p.m. Eastern Time on November 2, 2017, at http://www.achdncmeetings.org/. To ensure all individuals who have registered and requested time for oral comments are accommodated, the allocated time for comments may be limited. Individuals associated with groups or who plan to provide comments on similar topics may be asked to combine their comments and present them through a single representative. No audiovisual presentations are permitted. Written comments should identify the individual's name, address, email, telephone number, professional or organization affiliation, background or area of expertise (i.e., parent, family member, researcher, clinician, public health, etc.) and the topic/ subject matter. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Ann Ferrero using the address and phone number above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017-22313 Filed 10-13-17; 8:45 am] BILLING CODE 4165-15-P
![Federal Register / Vol. 82, No. 198 / Monday, October 16, 2017 / Notices 48103
In addition to the partnerships above, Bonus System in a fiscal year. HRSA structures to recognize the quality of
HRSA is seeking comment on state or would also seek to recognize the hospitals’ programs considering the
regional initiatives to consider when hospital’s level of engagement or different circumstances in which
establishing the qualifying standards for performance in the bonus amount. different children’s hospitals operate
the CHGME Quality Bonus System, as HRSA is also interested in gathering (e.g., patient severity, size of training
well as suggestions for how to views and suggestions on whether any programs, number of specialties trained,
distinguish between levels of of the existing information that etc.)
engagement and performance in a hospitals already report to the Centers of Frequency of Review: HRSA plans to
meaningful way. Medicare and Medicaid Services, HRSA, review and update the CHGME Quality
Documentation: To receive a quality accrediting bodies, and others could be Bonus System standards regularly to
bonus payment based upon engagement used to measure the performance of reflect changes in GME and advances in
in state- or regional-level pediatric GME programs and related health measuring GME outcomes.
health care transformation, CHGME outcomes for FY 2019 or subsequent Dated: October 5, 2017
hospitals would be required to submit a years. This could be individual George Sigounas,
letter from the lead organization, which measures or combinations of measures Administrator.
could include the project director for a that are reported to different entities.
[FR Doc. 2017–22381 Filed 10–13–17; 8:45 am]
HRSA-supported program or the state
Medicaid Director, confirming Quality Bonus Payment in FY 2020 and BILLING CODE 4165–15–P
participation by the children’s hospital Beyond—Areas for Public Comment
in the program and delineating the roles In future years, HRSA will refine the
CHGME Quality Bonus System to reflect DEPARTMENT OF HEALTH AND
and responsibilities of the children’s
the feedback received from HUMAN SERVICES
hospital in the program activities. In
addition, CHGME hospitals would be stakeholders, as well as advancements Health Resources and Service
required to submit a brief narrative in the development of standardized Administration
statement describing how CHGME GME quality measures. To that end,
trainees are integrated into state- or HRSA also is requesting comments on Advisory Committee on Heritable
regional-level pediatric health care several areas of the Quality Bonus Disorders in Newborns and Children
transformation activities and the System that will be implemented in FY
expected benefits for trainees and the 2020 and beyond. For long-term AGENCY: Health Resources and Service
health systems served by the children’s implementation, HRSA seeks public Administration (HRSA), Department of
hospital. HRSA is seeking comment on comments on the following areas: Health and Human Services (HHS).
this proposed approach including CHGME Hospital Eligibility: HRSA ACTION: Notice of meeting.
opportunities to limit burden and proposes to include all eligible CHGME
hospitals, including those newly SUMMARY: In accordance with the
streamline the documentation to Federal Advisory Committee Act, notice
determine whether applicants meet qualified, as eligible entities for the
CHGME Quality Bonus System. is hereby given that a meeting is
standards and distinguish among levels scheduled for the Advisory Committee
of engagement and performance. Quality Bonus System Measures:
HRSA is seeking comment on on Heritable Disorders in Newborns and
Payment Structure: HRSA proposes
appropriate GME outcome measures Children (ACHDNC). This meeting will
that CHGME hospitals that meet the
that can assess and distinguish be open to the public but advance
standards receive a portion of the registration is required. Please register
available funds for the CHGME Quality performance in meaningful ways. HRSA
is considering several GME outcome online at http://
Bonus System. HRSA proposes a three www.achdncmeetings.org/ by 12:00 p.m.
tiered payment structure to recognize measures including resident specialty
outcomes (e.g., number of graduates in Eastern Time on November 6, 2017.
the different annual payment levels Information about the ACHDNC can be
received by CHGME hospitals. Hospitals high need pediatric specialties), resident
service outcomes (e.g., service to high obtained by accessing the following
that meet the Quality Bonus Systems Web site: https://www.hrsa.gov/
standards will be evenly divided into need rural or underserved
communities), and children’s hospital advisorycommittees/mchbadvisory/
three tiers based on their combined heritabledisorders/index.html.
direct and indirect fiscal year payment quality outcomes. As noted above, these
measures could be existing measures DATES: The meeting will be held on
amounts, as calculated per the
established CHGME program formulas: that hospitals already report or new Wednesday, November 8, 2017, 9:30
Tier 1: Hospitals that qualify for the ones that would be developed or a.m. to 5:00 p.m. Eastern Time and
quality bonus payment that are in the improved for use in determining quality Thursday, November 9, 2017, 9:30 a.m.
lowest third among hospitals that bonuses. to 3:00 p.m. Eastern Time (meeting
qualify for the quality bonus payment of Data Sources: HRSA is seeking times are tentative).
calculated CHGME annual payments comment on available data sources on ADDRESSES: This meeting will be held
will receive a base payment. which to base the Quality Bonus in-person at 5600 Fishers Lane, 5th
Tier 2: Hospitals that qualify for the System. HRSA is requesting comment Floor Pavilion, Rockville, MD 20857.
quality bonus payment that are in the on data sources that are publicly The meeting will also be accessible via
middle third will receive two times the available, will streamline reporting Webcast. Instructions on how to access
base payment. requirements, and will limit burden on the meeting via Webcast will be
Tier 3: Hospitals that qualify for the CHGME programs. provided upon registration. Please note,
ethrower on DSK3G9T082PROD with NOTICES
quality bonus payment that are in the Tiering of Quality Bonus Payments: the 5600 Fishers Lane building requires
highest third will receive three times the HRSA is requesting comments on security screening on entry. Visitors
base payment. payment structures to recognize must provide a driver’s license,
The base payment rate would be hospitals according to their level of passport, or other form of government-
determined from the total amount engagement and/or outcomes while also issued photo identification to be granted
available and the number of hospitals taking into account the different size of entry into the facility. Non-US Citizens
that qualify for the CHGME Quality GME programs. The goal is for payment planning to attend in person will need
VerDate Sep<11>2014 16:59 Oct 13, 2017 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\16OCN1.SGM 16OCN1](https://thefederalregister.org/doc/82_FR_48301/page/1.svg)
![48104 Federal Register / Vol. 82, No. 198 / Monday, October 16, 2017 / Notices
to provide additional information to on the Committee’s Web site: http:// would constitute a clearly unwarranted
HRSA by October 24, 2017, 12:00 p.m. www.hrsa.gov/advisorycommittees/ invasion of personal privacy.
Eastern Time. Please see contact mchbadvisory/heritabledisorders. Name of Committee: National Institute of
information below. Members of the public will have the Allergy and Infectious Diseases Special
FOR FURTHER INFORMATION CONTACT: opportunity to provide comments. All Emphasis Panel; NIAID Clinical Trial
Anyone requesting information comments are part of the official Planning Grant (R34) and Implementation
regarding the ACHDNC should contact Committee record. To submit written Cooperative Agreement (U01).
Ann Ferrero, Maternal and Child Health comments or request time for an oral Date: November 6–9, 2017.
Time: 9:00 a.m. to 5:30 p.m.
Bureau (MCHB), HRSA, in one of three comment at the meeting, please register
Agenda: To review and evaluate grant
ways: (1) Send a request to the following online by 11:59 p.m. Eastern Time on applications.
address: Ann Ferrero, MCHB, HRSA November 2, 2017, at http:// Place: National Institutes of Health, 5601
5600 Fishers Lane, Room 18N100C, www.achdncmeetings.org/. To ensure Fishers Lane, Rockville, MD 20892,
Rockville, MD 20857; (2) call 301–443– all individuals who have registered and (Telephone Conference Call).
3999; or (3) send an email to: AFerrero@ requested time for oral comments are Contact Person: Geetanjali Bansal, Ph.D.,
hrsa.gov. accommodated, the allocated time for Scientific Review Officer, Scientific Review
SUPPLEMENTARY INFORMATION: The comments may be limited. Individuals Program, Division of Extramural Activities,
associated with groups or who plan to Room 3G49, National Institutes of Health/
ACHDNC provides advice to the NIAID, 5601 Fishers Lane, MSC 9834,
Secretary of HHS on the development of provide comments on similar topics
Bethesda, MD 20892–9834, (240) 669–5073,
newborn screening activities, may be asked to combine their geetanjali.bansal@nih.gov.
technologies, policies, guidelines, and comments and present them through a
(Catalogue of Federal Domestic Assistance
programs for effectively reducing single representative. No audiovisual Program Nos. 93.855, Allergy, Immunology,
morbidity and mortality in newborns presentations are permitted. Written and Transplantation Research; 93.856,
and children having, or at risk for, comments should identify the Microbiology and Infectious Diseases
heritable disorders. In addition, individual’s name, address, email, Research, National Institutes of Health, HHS)
ACHDNC’s recommendations regarding telephone number, professional or Dated: October 10, 2017.
inclusion of additional conditions and organization affiliation, background or
Natasha M. Copeland,
inherited disorders for screening which area of expertise (i.e., parent, family
Program Analyst, Office of Federal Advisory
have been adopted by the Secretary are member, researcher, clinician, public
Committee Policy.
then included in the Recommended health, etc.) and the topic/subject
[FR Doc. 2017–22259 Filed 10–13–17; 8:45 am]
Uniform Screening Panel (RUSP). matter.
BILLING CODE 4140–01–P
Conditions listed on the RUSP Individuals who plan to attend and
constitute part of the comprehensive need special assistance, such as sign
preventive health guidelines supported language interpretation or other DEPARTMENT OF HEALTH AND
by HRSA for infants and children under reasonable accommodations, should HUMAN SERVICES
section 2713 of the Public Health notify Ann Ferrero using the address
Service Act, codified at 42 U.S.C. and phone number above at least 10 National Institutes of Health
300gg–13. Under this provision, non- days prior to the meeting.
grandfathered health plans are required National Cancer Institute; Notice of
Amy McNulty,
to cover screenings included in the Closed Meeting
Acting Director, Division of the Executive
HRSA-supported comprehensive
Secretariat. Pursuant to section 10(d) of the
guidelines without charging a co-
payment, co-insurance, or deductible for [FR Doc. 2017–22313 Filed 10–13–17; 8:45 am] Federal Advisory Committee Act, as
plan years (i.e., policy years) beginning BILLING CODE 4165–15–P amended, notice is hereby given of the
on or after the date that is one year from following meeting.
the Secretary’s adoption of the The meeting will be closed to the
DEPARTMENT OF HEALTH AND public in accordance with the
condition for screening.
The meeting agenda will include: (1) HUMAN SERVICES provisions set forth in sections
An update on states’ progress toward 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institutes of Health as amended. The grant applications and
the newborn screening timeliness goals
outlined by the Committee; (2) a National Institute of Allergy and the discussions could disclose
presentation on phase 2 of the spinal Infectious Diseases; Notice of Closed confidential trade secrets or commercial
muscular atrophy evidence review; (3) Meeting property such as patentable material,
presentations on newborn screening and personal information concerning
topics such as the clinical and public Pursuant to section 10(d) of the individuals associated with the grant
health impact of Severe Combined Federal Advisory Committee Act, as applications, the disclosure of which
Immunodeficiency (SCID), carrier status amended, notice is hereby given of the would constitute a clearly unwarranted
in the context of newborn screening, following meeting. invasion of personal privacy.
and a review of long term follow up in The meeting will be closed to the Name of Committee: National Cancer
newborn screening; and (4) updates public in accordance with the Institute Special Emphasis Panel;
from the Laboratory Standards and provisions set forth in sections Translational Studies on Adducts For Cancer
Procedures workgroup, Follow-up and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Risk Identification and Prevention.
ethrower on DSK3G9T082PROD with NOTICES
Treatment workgroup, and Education as amended. The grant applications and Date: November 8, 2017.
and Training workgroup. The the discussions could disclose Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
Committee will not be voting on a confidential trade secrets or commercial applications.
proposed addition of a condition to the property such as patentable material, Place: National Cancer Institute, Shady
RUSP. Agenda items are subject to and personal information concerning Grove, 9609 Medical Center Drive, Room
change. The final meeting agenda will individuals associated with the grant 7W108, Rockville, MD 20850, (Telephone
be available 2 days prior to the meeting applications, the disclosure of which Conference Call).
VerDate Sep<11>2014 16:59 Oct 13, 2017 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\16OCN1.SGM 16OCN1](https://thefederalregister.org/doc/82_FR_48301/page/2.svg)
Document Created: 2017-10-14 01:42:37
Document Modified: 2017-10-14 01:42:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | The meeting will be held on Wednesday, November 8, 2017, 9:30 a.m. to 5:00 p.m. Eastern Time and Thursday, November 9, 2017, 9:30 a.m. to 3:00 p.m. Eastern Time (meeting times are tentative). | |
| Contact | Anyone requesting information regarding the ACHDNC should contact Ann Ferrero, Maternal and Child Health Bureau (MCHB), HRSA, in one of three ways: (1) Send a request to | |
| FR Citation | 82 FR 48103 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR